Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products across various global markets, including the United States, Europe, and Asia. The company operates through two primary segments: Life Science, which contributes approximately 55% of revenue, and Clinical Diagnostics, which accounts for about 45%. The Life Science segment focuses on reagents and instruments for research and biopharmaceutical production, serving customers such as universities, pharmaceutical manufacturers, and food testing laboratories. The Clinical Diagnostics segment provides test systems and kits for clinical laboratories, catering to hospitals and reference laboratories. Factors supporting the company's endurance include its established presence in niche markets and ongoing demand for diagnostic and research products, while potential limitations include competition and reliance on specific segments of the healthcare market.
—
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products across various global markets, including the United States, Europe, and Asia. The company operates through two primary segments: Life Science, which contributes approximately 55% of revenue, and Clinical Diagnostics, which accounts for about 45%. The Life Science segment focuses on reagents and instruments for research and biopharmaceutical production, serving customers such as universities, pharmaceutical manufacturers, and food testing laboratories. The Clinical Diagnostics segment provides test systems and kits for clinical laboratories, catering to hospitals and reference laboratories. Factors supporting the company's endurance include its established presence in niche markets and ongoing demand for diagnostic and research products, while potential limitations include competition and reliance on specific segments of the healthcare market.
—
Daily adjusted close
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products across various global markets, including the United States, Europe, and Asia. The company operates through two primary segments: Life Science, which contributes approximately 55% of revenue, and Clinical Diagnostics, which accounts for about 45%. The Life Science segment focuses on reagents and instruments for research and biopharmaceutical production, serving customers such as universities, pharmaceutical manufacturers, and food testing laboratories. The Clinical Diagnostics segment provides test systems and kits for clinical laboratories, catering to hospitals and reference laboratories. Factors supporting the company's endurance include its established presence in niche markets and ongoing demand for diagnostic and research products, while potential limitations include competition and reliance on specific segments of the healthcare market.